Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics

Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics

Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Nevertheless, the molecular mechanisms underlying the development of SCLC are unclear, requiring further investigation. The current research aims to identify relevant biomarkers and available drugs to t...

Full description

Bibliographic Details
Main Authors: Li Yi, Zhou Xiwen, Lyu Zhi
Format: Article
Language:English
Published: De Gruyter 2023-10-01
Series:Open Medicine
Subjects:
bioinformatics
biomarkers
small cell lung cancer
individualized diagnosis
targeted drugs
Online Access:https://doi.org/10.1515/med-2023-0806

Similar Items

Similar Items